期刊文献+

肝内胆管囊腺癌17例临床分析 被引量:5

Intrahepatic biliary cystadenocarcinoma of 17 cases DAI
原文传递
导出
摘要 目的分析肝内胆管囊腺癌的临床特点及治疗,探讨影响预后的相关因素。方法回顾性分析2002年1月至2007年9月共17例经手术病理证实为肝内胆管囊腺癌的临床资料,并进行随访。对预后的影响采用Cox回归分析和Kaplan—Meier分析。结果17例中男4例,女13例,平均年龄为49.3岁。患者以上腹痛为主要临床表现,仅2例患者CA19—9异常,2例CEA异常,17例患者AFP均正常。17例中行根治性手术7例,肿瘤完全切除联合取瘤栓术7例,姑息性手术3例。病理提示胆管囊腺癌10例,胆管囊腺瘤局部癌变2例,乳头状胆管囊腺癌2例,黏液性乳头状胆管囊腺癌2例;1例为肝内胆管囊腺癌与肝细胞癌双结节混合性癌。17例中肿瘤高分化7例,中分化3例,低分化7例。手术方式( β =-0.692,P=0.01)、肿瘤分化程度(p=-2.041,P=0.007)对预后影响有统计学意义。结论肝内胆管囊腺癌以成年女性多见。血清CA19-9对诊断无帮助。肝内胆管囊腺癌的胆总管癌栓并不预示临床预后差,行根治性手术或根治性切除联合取栓术均能有较好的预后。 Objective To explore the clinical features, treatment and prognosis of intrahepatic biliary cystadenocarcinoma (IBC). Methods We retrospectively analyzed clinical data of 17 patients with pathologically confirmed IBC, treated between January 2002 and September 2007. Results Of the 17 patients, 4 were men and 13 were women, with a mean age of 49. 3 years (range 45 -68). Serum level of AFP was normal in all patients. CA19-9 was abnormally elevated in only two patients and the other two had abnormal serum level of CEA. Seven cases underwent radical resection, 7 underwent complete tumor resection combined with removal of tumor thrombi in the bile duct, 3 received palliative surgery. On histopathological examination, 10 were biliary cystadenocarcinoma,2 were biliary cystadenoma with partial canceration,2 were papillary cystadenocarcinoma,2 were mucinous papillary cystadenocarcinoma and 1 was of mixed cystadenocarcinoma and hepatocellular carcinoma. According to tumor differentiation, the number of well, moderate and poor-differentiated group was 7, 3 and 7 cases respectively. The modality of surgery ( 13 = - 0. 692, P = 0. 01 ) and tumor differentiation ( β = - 2. 041, P = 0. 007 ) effected the prognosis significantly. Conclusions IBC occurs mainly in elderly women. CA19-9 examination does not help in the establishment of diagnosis of IBC. The occurrence of tumor thrombosis in common bile duct doesn't necessarily indicate poor prognosis, hence a IBC patient will still have a satisfactory prognosis should the primary tumor be completely resected and tumor thrombi removed.
出处 《中华普通外科杂志》 CSCD 北大核心 2008年第12期935-938,共4页 Chinese Journal of General Surgery
关键词 囊腺癌 胆管 肝内 病理学 临床 Cystadenocarcinoma Bile ducts, intrahepatic Pathology, clinical
  • 相关文献

参考文献8

  • 1Willis RA. Carcinoma arising in congenital cysts of the liver. Pathol Bacteriol, 1943, 50 : 492- 495.
  • 2Takayasu K,Muramatsu Y, Moriyama N, et al. Imaging diagnosis of bile duct cystadenocarcinoma. Cancer, 1958, 61:941-946.
  • 3Lewin M, Mourra N, Honigman I, et al. Assessment of MRI and MRCP in diagnosis of biliary cystadenoma and cystadenocarcinoma. Eur Radiol, 2006, 16:407- 413.
  • 4Patel AH,Harnosis DM,Klee G,et al. The utility of CA 19-9 in the diagnosis of eholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol, 2000, 95 : 204-207.
  • 5王震侠,贾乾斌,严律南,王文涛,周立新,焦作义,李晋.肝内胆管囊腺癌临床诊治分析(附11例报告)[J].癌症,2007,26(5):524-527. 被引量:9
  • 6Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma : a light microscopic and immunohistochemieal study of 70 patients. Am J Surg Pathol, 1994,18 : 1078-1091.
  • 7李志伟,冯玉泉,刘哲,于国.肝内胆管囊腺癌临床病理特点及治疗(附12例报告)[J].中华肝胆外科杂志,2002,8(6):362-365. 被引量:35
  • 8Kubota E, Katsumi K, Iida M, et al. Biliary cystadenocarcinoma followed up as benign cystadenoma for 10 years. J Gastroenterol, 2003,38:278-282.

二级参考文献12

  • 1于国 游联壁.肝内胆管性囊腺癌(附1例报告)[J].北京医学,1985,7:251-252.
  • 2Shrikhande S,Kleeff J,Adyanthaya K,et al.Management of hepatobiliary cystadenocarcinoma[J].Dig Surg,2003,20(1):60-63.
  • 3吴勇.肝胆管囊腺癌一例报告.癌症,2000,19(1):74-74.
  • 4Takayasu K,Muramatsu Y,Moriyama N,et al.Imaging diagnosis of bile duct cystadenocarcinoma[J].Cancer,1988,61 (5):941-946.
  • 5Devaney K,Goodman Z D,Ishak K G.Hepatobiliary cystadenoma and cystadenocarcinoma.A light microscopic and immunohistochemical study of 70 patients[J].Am J Surg Pathol,1994,18(11):1078-1091.
  • 6Nakajima T,Sugano I,Matsuzaki O,et al.Biliarycystadenocacinoma of the liver.A clinicopathologic and histochemical evaluation of nine cases[J].Cancer,1992,69(11):2426-2432.
  • 7Patel A H,Harnosis D M,Klee G,et al.The utility of CA19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis[J].Am J Gastroenterol,2000,95 (1):204-207.
  • 8Park K H,Kim J S,Lee J H,et al.Significances of serum level and immunohistochemical stain of CA19-9 in simple hepatic cysts and intrahepatic biliary cystic neoplasms[J].Korean J Gastroenterol,2006,47 (1):52-58.
  • 9Lewin M,Mourra N,Honigman l,et al.Assessment of MRI and MRCP in diagnosis of biliary cystadenoma and cystadenocarcinoma[J].Eur Radiol,2006,16(2):407-413.
  • 10Vogt D P,Henderson J M,Chmielewski E.Cystadenoma and cystadenocarcinoma of the liver:a single center experience[J].J Am Coll Surg,2005,200(5):727-733.

共引文献40

同被引文献24

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部